中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2015年
14期
9-10,11
,共3页
中西医结合%慢性阻塞性肺疾病%急性加重期
中西醫結閤%慢性阻塞性肺疾病%急性加重期
중서의결합%만성조새성폐질병%급성가중기
Integrated Chinese and Western medicines%Chronic obstructive pulmonary disease%Acute exacerbation
目的:观察中西医结合治疗慢性阻塞性肺疾病急性加重期(AECOPD)的临床疗效。方法130例慢性阻塞性肺疾病急性加重期患者采用数字表法随机分成治疗组(70例)和对照组(60例),两组均采用相同的常规西医综合治疗,治疗组在对照组的基础上结合中药治疗,观察两组的临床疗效及不良反应。结果治疗组总有效率92.86%,对照组总有效率80.00%,治疗组总有效率明显优于对照组,差异有统计学意义(P<0.05),两组均无明显不良反应发生。结论中西医结合治疗急性加重期慢性阻塞性肺疾病,疗效确切,安全性高,不良反应少,值得临床推广。
目的:觀察中西醫結閤治療慢性阻塞性肺疾病急性加重期(AECOPD)的臨床療效。方法130例慢性阻塞性肺疾病急性加重期患者採用數字錶法隨機分成治療組(70例)和對照組(60例),兩組均採用相同的常規西醫綜閤治療,治療組在對照組的基礎上結閤中藥治療,觀察兩組的臨床療效及不良反應。結果治療組總有效率92.86%,對照組總有效率80.00%,治療組總有效率明顯優于對照組,差異有統計學意義(P<0.05),兩組均無明顯不良反應髮生。結論中西醫結閤治療急性加重期慢性阻塞性肺疾病,療效確切,安全性高,不良反應少,值得臨床推廣。
목적:관찰중서의결합치료만성조새성폐질병급성가중기(AECOPD)적림상료효。방법130례만성조새성폐질병급성가중기환자채용수자표법수궤분성치료조(70례)화대조조(60례),량조균채용상동적상규서의종합치료,치료조재대조조적기출상결합중약치료,관찰량조적림상료효급불량반응。결과치료조총유효솔92.86%,대조조총유효솔80.00%,치료조총유효솔명현우우대조조,차이유통계학의의(P<0.05),량조균무명현불량반응발생。결론중서의결합치료급성가중기만성조새성폐질병,료효학절,안전성고,불량반응소,치득림상추엄。
Objective To observe the clinical effect of integrated Chinese and Western medicines in the treatment of acute exacerbation of chronic obstructive pulmonary disease.Methods A total of 130 patients with acute exacerbation of chronic obstructive pulmonary disease were divided by random number table into treatment group (70 cases) and control group (60 cases). Both groups received conventional Western comprehensive treatment, and the treatment group was given additional traditional Chinese medicine. Clinical effects and adverse reactions of the two groups were observed.Results The treatment group had the total effective rate as 92.86%, and that in the control group was 80.00%. The treatment group had much better total effective rate than the control group, and their difference had statistical significance (P<0.05). No obvious adverse reactions were found in the two groups.Conclusion Integrated Chinese and Western medicines provides precise effect in treating acute exacerbation of chronic obstructive pulmonary disease, with high safety and few adverse reactions. This method is worthy of clinical promotion.